KALOCYTE Trademark

Trademark Overview

On Thursday, July 11, 2024, a trademark application was filed for KALOCYTE with the United States Patent and Trademark Office. The USPTO has given the KALOCYTE trademark a serial number of 98644213. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, July 11, 2024. This trademark is owned by KALOCYTE, INC.. The KALOCYTE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific study and research in the fields of biotechnology, the prevention, treatment and management of illness, healthcare, and the development of bio-inspired artificial red blood cell
kalocyte

General Information

Serial Number98644213
Word MarkKALOCYTE
Filing DateThursday, July 11, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, July 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesScientific study and research in the fields of biotechnology, the prevention, treatment and management of illness, healthcare, and the development of bio-inspired artificial red blood cell

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 11, 2024
Primary Code042
First Use Anywhere DateTuesday, April 5, 2016
First Use In Commerce DateTuesday, April 5, 2016

Trademark Owner History

Party NameKALOCYTE, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21201

Trademark Events

Event DateEvent Description
Thursday, July 11, 2024NEW APPLICATION ENTERED
Thursday, July 11, 2024APPLICATION FILING RECEIPT MAILED

Related Keywords

kalocyte development healthcare inspired artificial cell blood illness management research study